Exact Sciences to Participate in September Investor Conferences

Audio By Carbonatix

MADISON, Wis.--(BUSINESS WIRE)--Aug 19, 2025--

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

• Wells Fargo Healthcare Conference, Boston
  Fireside chat on Wednesday, September 3, 2025 at 1:30 p.m. ET
• Baird Global Healthcare Conference, New York
  Fireside chat on Tuesday, September 9, 2025 at 10:50 a.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company’s growing portfolio includes well-established brands such as Cologuard® and Oncotype DX®, along with innovative solutions like Oncodetect™ for molecular residual disease and recurrence monitoring. Exact Sciences continues to invest in a robust pipeline of advanced cancer diagnostics aimed at improving outcomes. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250819553548/en/

CONTACT: Derek Leckow

Exact Sciences Corp.

[email protected]

608-893-0009

KEYWORD: WISCONSIN UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: GENERAL HEALTH HEALTH ONCOLOGY OTHER HEALTH

SOURCE: Exact Sciences Corp.

Copyright Business Wire 2025.

PUB: 08/19/2025 06:00 AM/DISC: 08/19/2025 05:59 AM

http://www.businesswire.com/news/home/20250819553548/en